drugset / Trial / NCT00210860
An Open Label Extension of a Study Comparing Topiramate and Amitriptyline in Migraine Prevention.
Phase 3
Completed
142 enrolled
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Ortho-McNeil Neurologics, Inc. · collab
Non-randomizedSingle-groupOpen-labelPrevention
Summary
The purpose of this study is to assess the long-term safety and effectiveness of topiramate for the prevention of migraine headaches in adults. Topiramate has been approved to prevent migraine headaches in adults.
Timeline
- Start
- 2004-09
- Primary completion
- —
- Completion
- 2006-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Topiramate | Small molecule | — | Oral |